Willow bark and bones & joints

What 3 graded rows on willow bark agree on for bones & joints, and where they differ. Counted side by side, never averaged.

What the rows agree on

Each block and row is one graded row from the Willow bark page, with its PubMed record.

Your question

Supplement
Willow bark Choose another

Willow bark and bones & joints

3 rows · 396 people

Mostly an improvement: 2 of 3 rows, and most of the people. 1 found no difference.

No difference
Improved
Each block is one evidence row, sized by how many people it enrolled, with its grade inside.
  • Grade B× 1
  • Grade D× 2
Rows
3
Trials
3
People
396

Where they differ

From the rows
How longWhen publishedGrade

The best-graded row, grade B, is a randomized trial of 191 people (2000) and found an improvement.

The row that found no difference ran longer (6 weeks) than the 2 rows that found an improvement (2 to 4 weeks).

The row that found no difference is newer (2004) than the 2 rows that found an improvement (2000 to 2001).

The best grade is B among the rows that found an improvement, and D among the row that found no difference.

The rows

2 improved · 1 no difference
  1. Grade BLow back pain flare-ups · Improved

    RCT · n 191 · 2000 · Adults with an exacerbation of chronic low back pain (210 enrolled)

    120 or 240 mg salicin/day · 4 weeks

    Pain-free without rescue tramadol in the final week: 39% (high dose), 21% (low dose), 6% (placebo); one person had a severe allergic reaction, possibly to the extract.

    Row on the Willow bark page · PubMed 10936472 (opens PubMed)

  2. Grade DOsteoarthritis pain · Improved

    RCT · n 78 · 2001 · Adults with osteoarthritis

    240 mg salicin/day · 2 weeks

    WOMAC pain fell 14% versus a 2% rise with placebo, a small but significant difference (6.5 mm).

    Row on the Willow bark page · PubMed 11406860 (opens PubMed)

  3. Grade DHip or knee osteoarthritis pain · No difference

    RCT · n 127 · 2004 · Outpatients with hip or knee osteoarthritis

    240 mg salicin/day · 6 weeks

    Pain fell 17% with willow bark, 47% with diclofenac and 10% with placebo; willow bark did not differ significantly from placebo. A 26-person rheumatoid arthritis trial was also negative.

    Row on the Willow bark page · PubMed 15517622 (opens PubMed)

Educational only. Not medical advice. Some links earn us a commission: kymatahealth.com/affiliate-disclosure.